Metharbital
Metharbital is a barbiturate derivative that has been used as an anticonvulsant in the treatment of epilepsy. It is known for its sedative and hypnotic properties, which make it effective in managing seizures and other related conditions.
Pharmacology[edit | edit source]
Metharbital works by depressing the central nervous system (CNS), which helps to reduce the frequency and severity of seizures. It enhances the activity of the gamma-aminobutyric acid (GABA) neurotransmitter, which is an inhibitory neurotransmitter in the CNS. This action helps to stabilize neuronal activity and prevent the abnormal electrical discharges that cause seizures.
Medical Uses[edit | edit source]
Metharbital is primarily used in the management of epilepsy, particularly in patients who do not respond well to other anticonvulsant medications. It may also be used for its sedative properties in the treatment of anxiety and insomnia.
Side Effects[edit | edit source]
Common side effects of metharbital include drowsiness, dizziness, and ataxia. Long-term use can lead to tolerance and dependence, and abrupt discontinuation may result in withdrawal symptoms. Other potential side effects include nausea, vomiting, and headache.
Contraindications[edit | edit source]
Metharbital is contraindicated in patients with a history of porphyria, severe liver disease, or respiratory depression. It should be used with caution in patients with a history of substance abuse or mental health disorders.
Dosage[edit | edit source]
The dosage of metharbital varies depending on the patient's age, weight, and the severity of the condition being treated. It is typically administered orally in tablet form, and the dosage must be carefully adjusted to achieve the desired therapeutic effect while minimizing side effects.
History[edit | edit source]
Metharbital was first synthesized in the early 20th century and has been used in clinical practice for several decades. Its use has declined with the development of newer anticonvulsant medications that have fewer side effects and a lower potential for abuse.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
